• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Mind Medicine Mindmed Inc (NQ: MNMD )

    9.260 +0.730 (+8.56%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 873,292
    Open 8.650
    Bid (Size) 9.260 (4)
    Ask (Size) 9.390 (1)
    Prev. Close 8.530
    Today's Range 8.570 - 9.600
    52wk Range 2.410 - 12.22
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    EXCLUSIVE: Legal Magic Mushroom Products Will Be Sold In Jamaica As Psilocybin Products Hit Pharmacy Shelves
    Jamaica introduces its first legal psilocybin products in pharmacies through a historic partnership between PATOO and Fontana Pharmacy. 
    Via Benzinga
    MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer
    From Mind Medicine Inc.
    Via Business Wire

    Performance

    YTD
    +155.80%
    +155.80%
    1 Month
    +30.98%
    +30.98%
    3 Month
    -1.80%
    -1.80%
    6 Month
    +139.90%
    +139.90%
    1 Year
    +89.37%
    +89.37%

    More News

    Read More
    MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT)
    From Mind Medicine Inc.
    Via Business Wire
    Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD
    Via Talk Markets
    3 Psychedelic Stocks to Ride to the Moon and Beyond
    Via InvestorPlace
    Exposures Product Safety
    FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals
    Via InvestorPlace
    Exposures Product Safety
    Clinical-Stage BioTech Drug Stocks Declined 13% In June
    Via Talk Markets
    MindMed to be Included in Russell 2000® and Russell 3000® Indexes
    From Mind Medicine Inc.
    Via Business Wire
    Groundbreaking Fentanyl Vaccine Being Developed To Prevent Fatal Overdoses, Startup Secures $10M
    Via Benzinga
    Largest Clinical-Stage BioTech Drug Stocks Declined 6%
    Via Talk Markets
    MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
    From Mind Medicine Inc.
    Via Business Wire
    MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD)
    From Mind Medicine
    Via Business Wire
    Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024
    Via InvestorPlace
    Largest Psychedelic Compound Based Drug Stocks Fell 13% Last Week - Here's Why
    Via Talk Markets
    Psychedelic Stocks Trip Up After FDA Advisors Reject MDMA For PTSD Treatment
    Via Benzinga
    Exposures Product Safety
    What's Going On With MindMed And Psychedelic Stocks?
    Via Benzinga
    DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
    Via Benzinga
    Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Why Stitch Fix Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    MindMed to Participate in June Conferences
    From Mind Medicine Inc.
    Via Business Wire
    Largest Clinical-Stage BioTech Drug Stocks Declined Slightly Last Week
    Via Talk Markets
    The Time Traveler’s Portfolio: 3 Stocks to Buy Now for Massive Returns by 2034
    Via InvestorPlace
    Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Jim Cramer: This Industrial Company Is 'Absolutely Terrific', Recommends Buying Modine Manufacturing
    Via Benzinga
    Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week
    Via Talk Markets
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.